ACTRN12612000385842
Recruiting
Phase 2
A randomised double-blind placebo-controlled trial of the efficacy of Remifentanil for procedural pain in neonates
Dr Susan M Lord0 sites80 target enrollmentApril 4, 2012
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Pain relief for neonates undergoing insertion of a central venous catheter
- Sponsor
- Dr Susan M Lord
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Medically stable neonates
- •Inpatient in JHCH NICU Level 3 Nursery
- •Require insertion of a central venous catheter for their medical care
- •24–44 weeks corrected gestational age at the time of procedure
Exclusion Criteria
- •Prior participation in this study (an infant can only participate once)
- •Major congenital anomalies
- •Severe hypoxic ischaemic encephalopathy
- •Current clinical seizures
- •Concomitant muscle relaxant
- •Emergency central line insertions
- •Lack of peripheral venous access for administration of study drug
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised double-blind placebo-controlled trial of the effect of vitamin and mineral supplements on morbidity from infections in men and women over 65 yearsMineral & vitamin supplementationNutritional, Metabolic, EndocrineISRCTN66376460Health Services Research Unit, University of Aberdeen (UK)910
Active, not recruiting
Not Applicable
A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopyEUCTR2004-002051-13-GBImperial College, London200
Completed
Not Applicable
Preemptive analgesia with bupivacaine in mastectomyBreast cancerCancerMalignant neoplasm of the breastISRCTN33898123Medical University of Gdansk (Poland)100
Completed
Phase 4
A randomised placebo-controlled trial to investigate the use of paracetamol in the treatment of influenzaACTRN12611000497909Medical Research Institute of New Zealand80
Completed
Not Applicable
Opti-Med: A randomised controlled trial of deprescribing to optimise health outcomes for frail older people.Medication use in older adults who are often frail with complex co-morbidity (co-existing medical conditions).Other - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12613001204730niversity of Western Australia954